Comparing two weight loss programs for kidney cancer patients
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests two different weight loss programs to see which one helps prevent kidney cancer from growing in people with small kidney masses who are under active surveillance. It may help by improving overall health and potentially slowing cancer progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a small kidney mass confirmed as kidney cancer by biopsy and are under active surveillance.
- Your body mass index (BMI) is 25 or higher (considered overweight or obese).
- You have not lost more than 5% of your body weight in the last 3 months.
- You have not had weight loss surgery in the last 10 years.
- You are not currently taking weight loss medication (or have not taken any in the past 3 months).
- You are not pregnant or breastfeeding, and have no medical conditions that would prevent safe participation in a weight loss program with exercise.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if people with advanced kidney cancer can safely stop all treatment if a special scan (PET/CT) shows their cancer has shrunk or disappeared. It's for those who have already been on a first-line immunotherapy plus targeted therapy for at least 12 months.
This trial compares two approaches for people with a certain type of early kidney cancer: taking two medications (anlotinib and benmelstobart) instead of having surgery to remove the tumor. The goal is to see if the medications work as well as or better than surgery at controlling the cancer.
This trial tests a modified intermittent eating plan to help people with obesity lose weight and keep it off. It compares different eating schedules to see which works best for long-term weight control.
This trial tests a special low-calorie diet (fasting-mimicking diet) combined with two types of medicine (immunotherapy and targeted therapy) for people with advanced kidney cancer. The diet might help the medicines work better.
This study tests if specific diet changes can help overweight women with endometrial cancer or atypical hyperplasia lose weight while undergoing fertility-sparing treatment.
This trial is testing whether adding a gut health supplement (CBM588) to the immunotherapy drug pembrolizumab can help prevent kidney cancer from returning after surgery. It is for people with certain types of kidney cancer who have not had immunotherapy before.
Hear when a new Renal Cell Carcinoma (RCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.